Exact Mass: 711.3703914

Exact Mass Matches: 711.3703914

Found 33 metabolites which its exact mass value is equals to given mass value 711.3703914, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

cyclopenta-1,3-diene,(1S)-1-(2-dicyclohexylphosphanylcyclopenta-2,4-dien-1-yl)-1-(2-dicyclohexylphosphanylphenyl)-N,N-dimethylmethanamine,iron(2+)

cyclopenta-1,3-diene,(1S)-1-(2-dicyclohexylphosphanylcyclopenta-2,4-dien-1-yl)-1-(2-dicyclohexylphosphanylphenyl)-N,N-dimethylmethanamine,iron(2+)

C43H63FeNP2 (711.3784888)


   
   
   

(s)-(+)-[(r)-2-dicyclohexylphosphinoferrocenyl](n,n-dimethylamino)(2-dicyclohexylphosphinophenyl)methane

(s)-(+)-[(r)-2-dicyclohexylphosphinoferrocenyl](n,n-dimethylamino)(2-dicyclohexylphosphinophenyl)methane

C43H63FeNP2 (711.3784888)


   
   

N-(2-aminophenyl)-N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]heptanediamide

N-(2-aminophenyl)-N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]heptanediamide

C38H48F3N5O5 (711.3607353999998)


   

N-(2-aminophenyl)-N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]heptanediamide

N-(2-aminophenyl)-N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]heptanediamide

C38H48F3N5O5 (711.3607353999998)


   

N-(2-aminophenyl)-N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]heptanediamide

N-(2-aminophenyl)-N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]heptanediamide

C38H48F3N5O5 (711.3607353999998)


   

N-(2-aminophenyl)-N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]heptanediamide

N-(2-aminophenyl)-N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]heptanediamide

C38H48F3N5O5 (711.3607353999998)


   

N-(2-aminophenyl)-N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]heptanediamide

N-(2-aminophenyl)-N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]heptanediamide

C38H48F3N5O5 (711.3607353999998)


   

N-(2-aminophenyl)-N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]heptanediamide

N-(2-aminophenyl)-N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]heptanediamide

C38H48F3N5O5 (711.3607353999998)


   

N-(2-aminophenyl)-N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]heptanediamide

N-(2-aminophenyl)-N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]heptanediamide

C38H48F3N5O5 (711.3607353999998)


   
   
   
   
   
   
   
   
   
   

LCKLSL (hydrochloride)

LCKLSL (hydrochloride)

C30H58ClN7O8S (711.3755898000001)


LCKLSL hydrochloride is a N-terminal hexapeptide and a competitive annexin A2 (AnxA2) inhibitor. LCKLSL hydrochloride potently inhibits the binding of tissue plasminogen activator (tPA) to AnxA2. LCKLSL hydrochloride also inhibits the generation of plasmin and has anti-angiogenic roles[1].

   

19-ethenyl-21,31,32,35-tetrahydroxy-11,13,15,17,19,26,28,29-octamethyl-8,30,33-trioxa-34-azanonacyclo[20.11.2.1³,⁷.1⁹,¹⁶.0¹,²³.0¹⁰,¹⁵.0²⁴,³².0²⁷,³¹.0²⁰,³⁶]heptatriaconta-3(37),4,6,17,21,26,34-heptaen-25-one

19-ethenyl-21,31,32,35-tetrahydroxy-11,13,15,17,19,26,28,29-octamethyl-8,30,33-trioxa-34-azanonacyclo[20.11.2.1³,⁷.1⁹,¹⁶.0¹,²³.0¹⁰,¹⁵.0²⁴,³².0²⁷,³¹.0²⁰,³⁶]heptatriaconta-3(37),4,6,17,21,26,34-heptaen-25-one

C43H53NO8 (711.3770978)


   

(?)-2α-acetoxy-2',7-dideacetoxy-1-hydroxy-11(15→1)-abeo-austrospicatine

NA

C39H53NO11 (711.3618428)


{"Ingredient_id": "HBIN005259","Ingredient_name": "(?)-2\u03b1-acetoxy-2',7-dideacetoxy-1-hydroxy-11(15\u21921)-abeo-austrospicatine","Alias": "NA","Ingredient_formula": "C39H53NO11","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "157","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

(+)-2alpha-acetoxy-2',7-dideacetoxy-1-hydroxy-austrospicatine

(+)-2α-acetoxy-2',7-dideacetoxy-1-hydroxy-austrospicatine

C39H53NO11 (711.3618428)


{"Ingredient_id": "HBIN005260","Ingredient_name": "(+)-2alpha-acetoxy-2',7-dideacetoxy-1-hydroxy-austrospicatine","Alias": "(+)-2\u03b1-acetoxy-2',7-dideacetoxy-1-hydroxy-austrospicatine","Ingredient_formula": "C39H53NO11","Ingredient_Smile": "CC1=C2C(C(C3(CCC(C(=C)C3C(C(C2(C)C)(CC1OC(=O)C)O)OC(=O)C)OC(=O)CC(C4=CC=CC=C4)N(C)C)C)OC(=O)C)OC(=O)C","Ingredient_weight": "711.8 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "25404;158","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "5320472","DrugBank_id": "NA"}

   

2alpha-hydroxy-2'beta-deacetylaustrospicatine

2α-hydroxy-2'β-deacetylaustrospicatine

C39H53NO11 (711.3618428)


{"Ingredient_id": "HBIN005282","Ingredient_name": "2alpha-hydroxy-2'beta-deacetylaustrospicatine","Alias": "2\u03b1-hydroxy-2'\u03b2-deacetylaustrospicatine","Ingredient_formula": "C39H53NO11","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "31173;9958","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

2'-deacetylaustrospicatine

NA

C39H53NO11 (711.3618428)


{"Ingredient_id": "HBIN005503","Ingredient_name": "2'-deacetylaustrospicatine","Alias": "NA","Ingredient_formula": "C39H53NO11","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4717","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

7beta-deacetylaustrospicatine

NA

C39H53NO11 (711.3618428)


{"Ingredient_id": "HBIN013099","Ingredient_name": "7beta-deacetylaustrospicatine","Alias": "NA","Ingredient_formula": "C39H53NO11","Ingredient_Smile": "CC1=C2C(C(C3(C(CC(C2(C)C)CC1OC(=O)C)C(=C)C(CC3O)OC(=O)C(C(C4=CC=CC=C4)N(C)C)OC(=O)C)C)OC(=O)C)OC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "26034","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

7-deacetylaustrospicatine

NA

C39H53NO11 (711.3618428)


{"Ingredient_id": "HBIN013142","Ingredient_name": "7-deacetylaustrospicatine","Alias": "NA","Ingredient_formula": "C39H53NO11","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4718","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

(2s,3as,4s,4ar,6s,8ar,9r,10r)-2,4,9,10-tetrakis(acetyloxy)-3a-(2-hydroxypropan-2-yl)-1,8a-dimethyl-5-methylidene-2h,3h,4h,4ah,6h,7h,8h,9h,10h-cyclohexa[f]azulen-6-yl (3r)-3-(dimethylamino)-3-phenylpropanoate

(2s,3as,4s,4ar,6s,8ar,9r,10r)-2,4,9,10-tetrakis(acetyloxy)-3a-(2-hydroxypropan-2-yl)-1,8a-dimethyl-5-methylidene-2h,3h,4h,4ah,6h,7h,8h,9h,10h-cyclohexa[f]azulen-6-yl (3r)-3-(dimethylamino)-3-phenylpropanoate

C39H53NO11 (711.3618428)


   

2,4,9,10-tetrakis(acetyloxy)-3a-(2-hydroxypropan-2-yl)-1,8a-dimethyl-5-methylidene-2h,3h,4h,4ah,6h,7h,8h,9h,10h-cyclohexa[f]azulen-6-yl 3-(dimethylamino)-3-phenylpropanoate

2,4,9,10-tetrakis(acetyloxy)-3a-(2-hydroxypropan-2-yl)-1,8a-dimethyl-5-methylidene-2h,3h,4h,4ah,6h,7h,8h,9h,10h-cyclohexa[f]azulen-6-yl 3-(dimethylamino)-3-phenylpropanoate

C39H53NO11 (711.3618428)


   

(1r,9s,10r,11s,13r,15s,16s,19s,20r,23r,24r,28s,29r,31r,32r,36s)-19-ethenyl-21,31,32,35-tetrahydroxy-11,13,15,17,19,26,28,29-octamethyl-8,30,33-trioxa-34-azanonacyclo[20.11.2.1³,⁷.1⁹,¹⁶.0¹,²³.0¹⁰,¹⁵.0²⁴,³².0²⁷,³¹.0²⁰,³⁶]heptatriaconta-3(37),4,6,17,21,26,34-heptaen-25-one

(1r,9s,10r,11s,13r,15s,16s,19s,20r,23r,24r,28s,29r,31r,32r,36s)-19-ethenyl-21,31,32,35-tetrahydroxy-11,13,15,17,19,26,28,29-octamethyl-8,30,33-trioxa-34-azanonacyclo[20.11.2.1³,⁷.1⁹,¹⁶.0¹,²³.0¹⁰,¹⁵.0²⁴,³².0²⁷,³¹.0²⁰,³⁶]heptatriaconta-3(37),4,6,17,21,26,34-heptaen-25-one

C43H53NO8 (711.3770978)